nodes	percent_of_prediction	percent_of_DWPC	metapath
Propantheline—Somnolence—Goserelin—breast cancer	0.00197	0.00243	CcSEcCtD
Propantheline—Feeling abnormal—Vinblastine—breast cancer	0.00197	0.00243	CcSEcCtD
Propantheline—Abdominal distension—Capecitabine—breast cancer	0.00194	0.00239	CcSEcCtD
Propantheline—Tachycardia—Vinorelbine—breast cancer	0.00194	0.00239	CcSEcCtD
Propantheline—Dysphagia—Capecitabine—breast cancer	0.00192	0.00237	CcSEcCtD
Propantheline—Salivary hypersecretion—Doxorubicin—breast cancer	0.00192	0.00237	CcSEcCtD
Propantheline—Hypersensitivity—Chlorambucil—breast cancer	0.00192	0.00237	CcSEcCtD
Propantheline—Nausea—Raloxifene—breast cancer	0.00191	0.00236	CcSEcCtD
Propantheline—Nausea—Idarubicin—breast cancer	0.00191	0.00236	CcSEcCtD
Propantheline—Confusional state—Thiotepa—breast cancer	0.00191	0.00236	CcSEcCtD
Propantheline—Constipation—Goserelin—breast cancer	0.00189	0.00234	CcSEcCtD
Propantheline—Vision blurred—Mitoxantrone—breast cancer	0.00189	0.00233	CcSEcCtD
Propantheline—Asthenia—Chlorambucil—breast cancer	0.00187	0.00231	CcSEcCtD
Propantheline—Tachycardia—Thiotepa—breast cancer	0.00185	0.00228	CcSEcCtD
Propantheline—Urticaria—Tamoxifen—breast cancer	0.00184	0.00227	CcSEcCtD
Propantheline—Feeling abnormal—Goserelin—breast cancer	0.00182	0.00225	CcSEcCtD
Propantheline—Vision blurred—Fluorouracil—breast cancer	0.00181	0.00223	CcSEcCtD
Propantheline—Urticaria—Melphalan—breast cancer	0.0018	0.00222	CcSEcCtD
Propantheline—Urticaria—Goserelin—breast cancer	0.00176	0.00217	CcSEcCtD
Propantheline—Hypersensitivity—Vinblastine—breast cancer	0.00176	0.00217	CcSEcCtD
Propantheline—Flushing—Paclitaxel—breast cancer	0.00174	0.00215	CcSEcCtD
Propantheline—Asthenia—Vinblastine—breast cancer	0.00171	0.00211	CcSEcCtD
Propantheline—Hypersensitivity—Tamoxifen—breast cancer	0.00171	0.00211	CcSEcCtD
Propantheline—Constipation—Vinorelbine—breast cancer	0.0017	0.00209	CcSEcCtD
Propantheline—Somnolence—Thiotepa—breast cancer	0.00168	0.00208	CcSEcCtD
Propantheline—Hypersensitivity—Melphalan—breast cancer	0.00167	0.00206	CcSEcCtD
Propantheline—Asthenia—Tamoxifen—breast cancer	0.00166	0.00205	CcSEcCtD
Propantheline—Vomiting—Chlorambucil—breast cancer	0.00166	0.00204	CcSEcCtD
Propantheline—Confusional state—Mitoxantrone—breast cancer	0.00165	0.00203	CcSEcCtD
Propantheline—Confusional state—Irinotecan—breast cancer	0.00165	0.00203	CcSEcCtD
Propantheline—Anaphylactic shock—Irinotecan—breast cancer	0.00164	0.00202	CcSEcCtD
Propantheline—Anaphylactic shock—Mitoxantrone—breast cancer	0.00164	0.00202	CcSEcCtD
Propantheline—Feeling abnormal—Vinorelbine—breast cancer	0.00163	0.00202	CcSEcCtD
Propantheline—Hypersensitivity—Goserelin—breast cancer	0.00163	0.00201	CcSEcCtD
Propantheline—Asthenia—Melphalan—breast cancer	0.00163	0.00201	CcSEcCtD
Propantheline—Constipation—Thiotepa—breast cancer	0.00162	0.002	CcSEcCtD
Propantheline—Tension—Paclitaxel—breast cancer	0.0016	0.00198	CcSEcCtD
Propantheline—Tachycardia—Mitoxantrone—breast cancer	0.0016	0.00197	CcSEcCtD
Propantheline—Anaphylactic shock—Gemcitabine—breast cancer	0.00159	0.00197	CcSEcCtD
Propantheline—Asthenia—Goserelin—breast cancer	0.00159	0.00196	CcSEcCtD
Propantheline—Nervousness—Paclitaxel—breast cancer	0.00159	0.00196	CcSEcCtD
Propantheline—Confusional state—Fluorouracil—breast cancer	0.00158	0.00195	CcSEcCtD
Propantheline—Dizziness—Vinblastine—breast cancer	0.00158	0.00195	CcSEcCtD
Propantheline—Urticaria—Vinorelbine—breast cancer	0.00158	0.00194	CcSEcCtD
Propantheline—Anaphylactic shock—Fluorouracil—breast cancer	0.00157	0.00193	CcSEcCtD
Propantheline—Feeling abnormal—Thiotepa—breast cancer	0.00156	0.00193	CcSEcCtD
Propantheline—Nausea—Chlorambucil—breast cancer	0.00155	0.00191	CcSEcCtD
Propantheline—Vision blurred—Paclitaxel—breast cancer	0.00154	0.0019	CcSEcCtD
Propantheline—Dizziness—Tamoxifen—breast cancer	0.00153	0.00189	CcSEcCtD
Propantheline—Tachycardia—Fluorouracil—breast cancer	0.00153	0.00189	CcSEcCtD
Propantheline—Vomiting—Vinblastine—breast cancer	0.00152	0.00187	CcSEcCtD
Propantheline—Urticaria—Thiotepa—breast cancer	0.0015	0.00186	CcSEcCtD
Propantheline—Headache—Vinblastine—breast cancer	0.00149	0.00184	CcSEcCtD
Propantheline—Insomnia—Irinotecan—breast cancer	0.00148	0.00183	CcSEcCtD
Propantheline—Flushing—Docetaxel—breast cancer	0.00148	0.00182	CcSEcCtD
Propantheline—Vomiting—Tamoxifen—breast cancer	0.00147	0.00182	CcSEcCtD
Propantheline—Dizziness—Goserelin—breast cancer	0.00146	0.00181	CcSEcCtD
Propantheline—Rash—Tamoxifen—breast cancer	0.00146	0.0018	CcSEcCtD
Propantheline—Hypersensitivity—Vinorelbine—breast cancer	0.00146	0.0018	CcSEcCtD
Propantheline—Dermatitis—Tamoxifen—breast cancer	0.00146	0.0018	CcSEcCtD
Propantheline—Somnolence—Irinotecan—breast cancer	0.00145	0.00179	CcSEcCtD
Propantheline—Somnolence—Mitoxantrone—breast cancer	0.00145	0.00179	CcSEcCtD
Propantheline—Headache—Tamoxifen—breast cancer	0.00145	0.00179	CcSEcCtD
Propantheline—Palpitations—Paclitaxel—breast cancer	0.00144	0.00178	CcSEcCtD
Propantheline—Vomiting—Melphalan—breast cancer	0.00144	0.00178	CcSEcCtD
Propantheline—Insomnia—Gemcitabine—breast cancer	0.00144	0.00178	CcSEcCtD
Propantheline—Rash—Melphalan—breast cancer	0.00143	0.00177	CcSEcCtD
Propantheline—Flushing—Capecitabine—breast cancer	0.00143	0.00176	CcSEcCtD
Propantheline—Dermatitis—Melphalan—breast cancer	0.00143	0.00176	CcSEcCtD
Propantheline—Asthenia—Vinorelbine—breast cancer	0.00142	0.00176	CcSEcCtD
Propantheline—Nausea—Vinblastine—breast cancer	0.00142	0.00175	CcSEcCtD
Propantheline—Insomnia—Fluorouracil—breast cancer	0.00142	0.00175	CcSEcCtD
Propantheline—Somnolence—Gemcitabine—breast cancer	0.00142	0.00175	CcSEcCtD
Propantheline—Vomiting—Goserelin—breast cancer	0.00141	0.00174	CcSEcCtD
Propantheline—Constipation—Irinotecan—breast cancer	0.0014	0.00173	CcSEcCtD
Propantheline—Constipation—Mitoxantrone—breast cancer	0.0014	0.00173	CcSEcCtD
Propantheline—Rash—Goserelin—breast cancer	0.0014	0.00172	CcSEcCtD
Propantheline—Hypersensitivity—Thiotepa—breast cancer	0.0014	0.00172	CcSEcCtD
Propantheline—Dermatitis—Goserelin—breast cancer	0.00139	0.00172	CcSEcCtD
Propantheline—Somnolence—Fluorouracil—breast cancer	0.00139	0.00172	CcSEcCtD
Propantheline—Headache—Goserelin—breast cancer	0.00139	0.00171	CcSEcCtD
Propantheline—Nausea—Tamoxifen—breast cancer	0.00138	0.0017	CcSEcCtD
Propantheline—Constipation—Gemcitabine—breast cancer	0.00136	0.00168	CcSEcCtD
Propantheline—Dry mouth—Paclitaxel—breast cancer	0.00136	0.00168	CcSEcCtD
Propantheline—Asthenia—Thiotepa—breast cancer	0.00136	0.00168	CcSEcCtD
Propantheline—Abdominal distension—Epirubicin—breast cancer	0.00135	0.00167	CcSEcCtD
Propantheline—Nausea—Melphalan—breast cancer	0.00135	0.00166	CcSEcCtD
Propantheline—Feeling abnormal—Irinotecan—breast cancer	0.00135	0.00166	CcSEcCtD
Propantheline—Feeling abnormal—Mitoxantrone—breast cancer	0.00135	0.00166	CcSEcCtD
Propantheline—Confusional state—Paclitaxel—breast cancer	0.00134	0.00166	CcSEcCtD
Propantheline—Dysphagia—Epirubicin—breast cancer	0.00134	0.00165	CcSEcCtD
Propantheline—Anaphylactic shock—Paclitaxel—breast cancer	0.00133	0.00165	CcSEcCtD
Propantheline—Erectile dysfunction—Methotrexate—breast cancer	0.00132	0.00163	CcSEcCtD
Propantheline—Nausea—Goserelin—breast cancer	0.00132	0.00162	CcSEcCtD
Propantheline—Feeling abnormal—Gemcitabine—breast cancer	0.00131	0.00162	CcSEcCtD
Propantheline—Dizziness—Vinorelbine—breast cancer	0.00131	0.00162	CcSEcCtD
Propantheline—Tachycardia—Paclitaxel—breast cancer	0.0013	0.00161	CcSEcCtD
Propantheline—Urticaria—Mitoxantrone—breast cancer	0.0013	0.0016	CcSEcCtD
Propantheline—Feeling abnormal—Fluorouracil—breast cancer	0.00129	0.00159	CcSEcCtD
Propantheline—Drowsiness—Methotrexate—breast cancer	0.00128	0.00158	CcSEcCtD
Propantheline—Vision blurred—Capecitabine—breast cancer	0.00126	0.00156	CcSEcCtD
Propantheline—Vomiting—Vinorelbine—breast cancer	0.00126	0.00156	CcSEcCtD
Propantheline—Dizziness—Thiotepa—breast cancer	0.00125	0.00155	CcSEcCtD
Propantheline—Rash—Vinorelbine—breast cancer	0.00125	0.00154	CcSEcCtD
Propantheline—Dermatitis—Vinorelbine—breast cancer	0.00125	0.00154	CcSEcCtD
Propantheline—Abdominal distension—Doxorubicin—breast cancer	0.00125	0.00154	CcSEcCtD
Propantheline—Urticaria—Fluorouracil—breast cancer	0.00124	0.00154	CcSEcCtD
Propantheline—Headache—Vinorelbine—breast cancer	0.00124	0.00153	CcSEcCtD
Propantheline—Dysphagia—Doxorubicin—breast cancer	0.00124	0.00153	CcSEcCtD
Propantheline—Palpitations—Docetaxel—breast cancer	0.00122	0.00151	CcSEcCtD
Propantheline—Insomnia—Paclitaxel—breast cancer	0.00121	0.00149	CcSEcCtD
Propantheline—Hypersensitivity—Mitoxantrone—breast cancer	0.0012	0.00149	CcSEcCtD
Propantheline—Hypersensitivity—Irinotecan—breast cancer	0.0012	0.00149	CcSEcCtD
Propantheline—Vomiting—Thiotepa—breast cancer	0.0012	0.00149	CcSEcCtD
Propantheline—Drowsiness—Epirubicin—breast cancer	0.0012	0.00148	CcSEcCtD
Propantheline—Rash—Thiotepa—breast cancer	0.00119	0.00147	CcSEcCtD
Propantheline—Dermatitis—Thiotepa—breast cancer	0.00119	0.00147	CcSEcCtD
Propantheline—Headache—Thiotepa—breast cancer	0.00119	0.00146	CcSEcCtD
Propantheline—Somnolence—Paclitaxel—breast cancer	0.00119	0.00146	CcSEcCtD
Propantheline—Palpitations—Capecitabine—breast cancer	0.00119	0.00146	CcSEcCtD
Propantheline—Nausea—Vinorelbine—breast cancer	0.00118	0.00145	CcSEcCtD
Propantheline—Asthenia—Irinotecan—breast cancer	0.00117	0.00145	CcSEcCtD
Propantheline—Asthenia—Mitoxantrone—breast cancer	0.00117	0.00145	CcSEcCtD
Propantheline—Hypersensitivity—Fluorouracil—breast cancer	0.00115	0.00142	CcSEcCtD
Propantheline—Dry mouth—Docetaxel—breast cancer	0.00115	0.00142	CcSEcCtD
Propantheline—Asthenia—Gemcitabine—breast cancer	0.00114	0.00141	CcSEcCtD
Propantheline—Constipation—Paclitaxel—breast cancer	0.00114	0.00141	CcSEcCtD
Propantheline—Confusional state—Docetaxel—breast cancer	0.00114	0.00141	CcSEcCtD
Propantheline—Anaphylactic shock—Docetaxel—breast cancer	0.00113	0.00139	CcSEcCtD
Propantheline—Nausea—Thiotepa—breast cancer	0.00112	0.00139	CcSEcCtD
Propantheline—Dry mouth—Capecitabine—breast cancer	0.00112	0.00138	CcSEcCtD
Propantheline—Drowsiness—Doxorubicin—breast cancer	0.00111	0.00137	CcSEcCtD
Propantheline—Confusional state—Capecitabine—breast cancer	0.0011	0.00136	CcSEcCtD
Propantheline—Tachycardia—Docetaxel—breast cancer	0.0011	0.00136	CcSEcCtD
Propantheline—Feeling abnormal—Paclitaxel—breast cancer	0.0011	0.00136	CcSEcCtD
Propantheline—Dizziness—Irinotecan—breast cancer	0.00108	0.00133	CcSEcCtD
Propantheline—Tachycardia—Capecitabine—breast cancer	0.00107	0.00132	CcSEcCtD
Propantheline—Urticaria—Paclitaxel—breast cancer	0.00106	0.00131	CcSEcCtD
Propantheline—Vomiting—Mitoxantrone—breast cancer	0.00104	0.00128	CcSEcCtD
Propantheline—Vomiting—Irinotecan—breast cancer	0.00104	0.00128	CcSEcCtD
Propantheline—Dizziness—Fluorouracil—breast cancer	0.00104	0.00128	CcSEcCtD
Propantheline—Rash—Mitoxantrone—breast cancer	0.00103	0.00127	CcSEcCtD
Propantheline—Rash—Irinotecan—breast cancer	0.00103	0.00127	CcSEcCtD
Propantheline—Dermatitis—Mitoxantrone—breast cancer	0.00103	0.00127	CcSEcCtD
Propantheline—Dermatitis—Irinotecan—breast cancer	0.00103	0.00127	CcSEcCtD
Propantheline—Headache—Mitoxantrone—breast cancer	0.00102	0.00126	CcSEcCtD
Propantheline—Headache—Irinotecan—breast cancer	0.00102	0.00126	CcSEcCtD
Propantheline—Insomnia—Docetaxel—breast cancer	0.00102	0.00126	CcSEcCtD
Propantheline—Vomiting—Gemcitabine—breast cancer	0.00101	0.00125	CcSEcCtD
Propantheline—Somnolence—Docetaxel—breast cancer	0.001	0.00124	CcSEcCtD
Propantheline—Rash—Gemcitabine—breast cancer	0.001	0.00124	CcSEcCtD
Propantheline—Dermatitis—Gemcitabine—breast cancer	0.001	0.00124	CcSEcCtD
Propantheline—Headache—Gemcitabine—breast cancer	0.000998	0.00123	CcSEcCtD
Propantheline—Flushing—Epirubicin—breast cancer	0.000996	0.00123	CcSEcCtD
Propantheline—Vomiting—Fluorouracil—breast cancer	0.000996	0.00123	CcSEcCtD
Propantheline—Insomnia—Capecitabine—breast cancer	0.00099	0.00122	CcSEcCtD
Propantheline—Rash—Fluorouracil—breast cancer	0.000988	0.00122	CcSEcCtD
Propantheline—Dermatitis—Fluorouracil—breast cancer	0.000987	0.00122	CcSEcCtD
Propantheline—Hypersensitivity—Paclitaxel—breast cancer	0.000983	0.00121	CcSEcCtD
Propantheline—Headache—Fluorouracil—breast cancer	0.000981	0.00121	CcSEcCtD
Propantheline—Nausea—Mitoxantrone—breast cancer	0.000971	0.0012	CcSEcCtD
Propantheline—Nausea—Irinotecan—breast cancer	0.000971	0.0012	CcSEcCtD
Propantheline—Constipation—Docetaxel—breast cancer	0.000967	0.00119	CcSEcCtD
Propantheline—Asthenia—Paclitaxel—breast cancer	0.000957	0.00118	CcSEcCtD
Propantheline—Nausea—Gemcitabine—breast cancer	0.000946	0.00117	CcSEcCtD
Propantheline—Vision blurred—Methotrexate—breast cancer	0.000941	0.00116	CcSEcCtD
Propantheline—Constipation—Capecitabine—breast cancer	0.000936	0.00115	CcSEcCtD
Propantheline—Feeling abnormal—Docetaxel—breast cancer	0.000932	0.00115	CcSEcCtD
Propantheline—Nausea—Fluorouracil—breast cancer	0.00093	0.00115	CcSEcCtD
Propantheline—Flushing—Doxorubicin—breast cancer	0.000922	0.00114	CcSEcCtD
Propantheline—Tension—Epirubicin—breast cancer	0.000917	0.00113	CcSEcCtD
Propantheline—Nervousness—Epirubicin—breast cancer	0.000907	0.00112	CcSEcCtD
Propantheline—Feeling abnormal—Capecitabine—breast cancer	0.000902	0.00111	CcSEcCtD
Propantheline—Dizziness—Paclitaxel—breast cancer	0.000882	0.00109	CcSEcCtD
Propantheline—Vision blurred—Epirubicin—breast cancer	0.00088	0.00109	CcSEcCtD
Propantheline—Urticaria—Capecitabine—breast cancer	0.000869	0.00107	CcSEcCtD
Propantheline—Tension—Doxorubicin—breast cancer	0.000848	0.00105	CcSEcCtD
Propantheline—Vomiting—Paclitaxel—breast cancer	0.000848	0.00105	CcSEcCtD
Propantheline—Rash—Paclitaxel—breast cancer	0.000841	0.00104	CcSEcCtD
Propantheline—Dermatitis—Paclitaxel—breast cancer	0.00084	0.00104	CcSEcCtD
Propantheline—Nervousness—Doxorubicin—breast cancer	0.00084	0.00104	CcSEcCtD
Propantheline—Headache—Paclitaxel—breast cancer	0.000836	0.00103	CcSEcCtD
Propantheline—Hypersensitivity—Docetaxel—breast cancer	0.000833	0.00103	CcSEcCtD
Propantheline—Palpitations—Epirubicin—breast cancer	0.000826	0.00102	CcSEcCtD
Propantheline—Confusional state—Methotrexate—breast cancer	0.000822	0.00101	CcSEcCtD
Propantheline—Anaphylactic shock—Methotrexate—breast cancer	0.000815	0.00101	CcSEcCtD
Propantheline—Vision blurred—Doxorubicin—breast cancer	0.000815	0.00101	CcSEcCtD
Propantheline—Asthenia—Docetaxel—breast cancer	0.000811	0.001	CcSEcCtD
Propantheline—Hypersensitivity—Capecitabine—breast cancer	0.000806	0.000995	CcSEcCtD
Propantheline—Nausea—Paclitaxel—breast cancer	0.000792	0.000978	CcSEcCtD
Propantheline—Asthenia—Capecitabine—breast cancer	0.000785	0.000969	CcSEcCtD
Propantheline—Dry mouth—Epirubicin—breast cancer	0.000778	0.00096	CcSEcCtD
Propantheline—Confusional state—Epirubicin—breast cancer	0.000769	0.000949	CcSEcCtD
Propantheline—Palpitations—Doxorubicin—breast cancer	0.000764	0.000943	CcSEcCtD
Propantheline—Anaphylactic shock—Epirubicin—breast cancer	0.000762	0.000941	CcSEcCtD
Propantheline—Dizziness—Docetaxel—breast cancer	0.000748	0.000922	CcSEcCtD
Propantheline—Tachycardia—Epirubicin—breast cancer	0.000744	0.000918	CcSEcCtD
Propantheline—Insomnia—Methotrexate—breast cancer	0.000737	0.000909	CcSEcCtD
Propantheline—Somnolence—Methotrexate—breast cancer	0.000724	0.000894	CcSEcCtD
Propantheline—Dizziness—Capecitabine—breast cancer	0.000724	0.000893	CcSEcCtD
Propantheline—Dry mouth—Doxorubicin—breast cancer	0.00072	0.000888	CcSEcCtD
Propantheline—Vomiting—Docetaxel—breast cancer	0.000719	0.000887	CcSEcCtD
Propantheline—Rash—Docetaxel—breast cancer	0.000713	0.00088	CcSEcCtD
Propantheline—Dermatitis—Docetaxel—breast cancer	0.000712	0.000879	CcSEcCtD
Propantheline—Confusional state—Doxorubicin—breast cancer	0.000711	0.000878	CcSEcCtD
Propantheline—Headache—Docetaxel—breast cancer	0.000708	0.000874	CcSEcCtD
Propantheline—Anaphylactic shock—Doxorubicin—breast cancer	0.000706	0.000871	CcSEcCtD
Propantheline—Vomiting—Capecitabine—breast cancer	0.000696	0.000859	CcSEcCtD
Propantheline—Rash—Capecitabine—breast cancer	0.00069	0.000852	CcSEcCtD
Propantheline—Insomnia—Epirubicin—breast cancer	0.00069	0.000851	CcSEcCtD
Propantheline—Dermatitis—Capecitabine—breast cancer	0.000689	0.000851	CcSEcCtD
Propantheline—Tachycardia—Doxorubicin—breast cancer	0.000689	0.00085	CcSEcCtD
Propantheline—Headache—Capecitabine—breast cancer	0.000686	0.000846	CcSEcCtD
Propantheline—Somnolence—Epirubicin—breast cancer	0.000678	0.000836	CcSEcCtD
Propantheline—Nausea—Docetaxel—breast cancer	0.000671	0.000829	CcSEcCtD
Propantheline—Feeling abnormal—Methotrexate—breast cancer	0.000671	0.000829	CcSEcCtD
Propantheline—Constipation—Epirubicin—breast cancer	0.000652	0.000805	CcSEcCtD
Propantheline—Nausea—Capecitabine—breast cancer	0.00065	0.000802	CcSEcCtD
Propantheline—Urticaria—Methotrexate—breast cancer	0.000647	0.000799	CcSEcCtD
Propantheline—Insomnia—Doxorubicin—breast cancer	0.000638	0.000787	CcSEcCtD
Propantheline—Feeling abnormal—Epirubicin—breast cancer	0.000628	0.000775	CcSEcCtD
Propantheline—Somnolence—Doxorubicin—breast cancer	0.000627	0.000774	CcSEcCtD
Propantheline—Urticaria—Epirubicin—breast cancer	0.000606	0.000747	CcSEcCtD
Propantheline—Constipation—Doxorubicin—breast cancer	0.000603	0.000744	CcSEcCtD
Propantheline—Hypersensitivity—Methotrexate—breast cancer	0.0006	0.000741	CcSEcCtD
Propantheline—Asthenia—Methotrexate—breast cancer	0.000585	0.000721	CcSEcCtD
Propantheline—Feeling abnormal—Doxorubicin—breast cancer	0.000581	0.000717	CcSEcCtD
Propantheline—Hypersensitivity—Epirubicin—breast cancer	0.000562	0.000693	CcSEcCtD
Propantheline—Urticaria—Doxorubicin—breast cancer	0.00056	0.000692	CcSEcCtD
Propantheline—Asthenia—Epirubicin—breast cancer	0.000547	0.000675	CcSEcCtD
Propantheline—Dizziness—Methotrexate—breast cancer	0.000539	0.000665	CcSEcCtD
Propantheline—Hypersensitivity—Doxorubicin—breast cancer	0.00052	0.000641	CcSEcCtD
Propantheline—Vomiting—Methotrexate—breast cancer	0.000518	0.000639	CcSEcCtD
Propantheline—Rash—Methotrexate—breast cancer	0.000514	0.000634	CcSEcCtD
Propantheline—Dermatitis—Methotrexate—breast cancer	0.000513	0.000633	CcSEcCtD
Propantheline—Headache—Methotrexate—breast cancer	0.00051	0.00063	CcSEcCtD
Propantheline—Asthenia—Doxorubicin—breast cancer	0.000506	0.000625	CcSEcCtD
Propantheline—Dizziness—Epirubicin—breast cancer	0.000504	0.000622	CcSEcCtD
Propantheline—Vomiting—Epirubicin—breast cancer	0.000485	0.000598	CcSEcCtD
Propantheline—Nausea—Methotrexate—breast cancer	0.000484	0.000597	CcSEcCtD
Propantheline—Rash—Epirubicin—breast cancer	0.000481	0.000593	CcSEcCtD
Propantheline—Dermatitis—Epirubicin—breast cancer	0.00048	0.000593	CcSEcCtD
Propantheline—Headache—Epirubicin—breast cancer	0.000478	0.000589	CcSEcCtD
Propantheline—Dizziness—Doxorubicin—breast cancer	0.000467	0.000576	CcSEcCtD
Propantheline—Nausea—Epirubicin—breast cancer	0.000453	0.000559	CcSEcCtD
Propantheline—Vomiting—Doxorubicin—breast cancer	0.000449	0.000554	CcSEcCtD
Propantheline—Rash—Doxorubicin—breast cancer	0.000445	0.000549	CcSEcCtD
Propantheline—Dermatitis—Doxorubicin—breast cancer	0.000444	0.000548	CcSEcCtD
Propantheline—Headache—Doxorubicin—breast cancer	0.000442	0.000545	CcSEcCtD
Propantheline—Nausea—Doxorubicin—breast cancer	0.000419	0.000517	CcSEcCtD
Propantheline—CHRM2—Signaling Pathways—ITPR1—breast cancer	4.76e-05	0.000251	CbGpPWpGaD
Propantheline—CHRM3—Metabolism—MTHFR—breast cancer	4.74e-05	0.00025	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—STAT5A—breast cancer	4.72e-05	0.000249	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—ERBB4—breast cancer	4.72e-05	0.000249	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—MMP3—breast cancer	4.72e-05	0.000249	CbGpPWpGaD
Propantheline—CHRM2—GPCR downstream signaling—PIK3CB—breast cancer	4.71e-05	0.000248	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—SMAD4—breast cancer	4.64e-05	0.000244	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—SMAD4—breast cancer	4.62e-05	0.000244	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—IGF1R—breast cancer	4.61e-05	0.000243	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—IGF1R—breast cancer	4.59e-05	0.000242	CbGpPWpGaD
Propantheline—CHRM1—GPCR downstream signaling—CXCL8—breast cancer	4.59e-05	0.000242	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—SMAD4—breast cancer	4.58e-05	0.000241	CbGpPWpGaD
Propantheline—CHRM3—GPCR downstream signaling—CXCL8—breast cancer	4.57e-05	0.000241	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—IGF1R—breast cancer	4.55e-05	0.00024	CbGpPWpGaD
Propantheline—CHRM2—GPCR downstream signaling—CXCL8—breast cancer	4.53e-05	0.000239	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—HES1—breast cancer	4.53e-05	0.000239	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—HES1—breast cancer	4.51e-05	0.000238	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—PLA2G4A—breast cancer	4.5e-05	0.000237	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—NCOR1—breast cancer	4.5e-05	0.000237	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—NCOR1—breast cancer	4.49e-05	0.000237	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—PLA2G4A—breast cancer	4.49e-05	0.000237	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—HES1—breast cancer	4.47e-05	0.000236	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—FGF1—breast cancer	4.45e-05	0.000235	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—CSF2—breast cancer	4.45e-05	0.000235	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—PLA2G4A—breast cancer	4.44e-05	0.000234	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—NCOR1—breast cancer	4.44e-05	0.000234	CbGpPWpGaD
Propantheline—CHRM1—Signaling by GPCR—RAF1—breast cancer	4.44e-05	0.000234	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—FGF1—breast cancer	4.44e-05	0.000234	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—CSF2—breast cancer	4.44e-05	0.000234	CbGpPWpGaD
Propantheline—CHRM3—Signaling by GPCR—RAF1—breast cancer	4.42e-05	0.000233	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—NRG1—breast cancer	4.42e-05	0.000233	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—NRG1—breast cancer	4.4e-05	0.000232	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—CSF2—breast cancer	4.39e-05	0.000232	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—FGF1—breast cancer	4.39e-05	0.000232	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—H2AFX—breast cancer	4.39e-05	0.000231	CbGpPWpGaD
Propantheline—CHRM1—GPCR downstream signaling—IL2—breast cancer	4.38e-05	0.000231	CbGpPWpGaD
Propantheline—CHRM2—Signaling by GPCR—RAF1—breast cancer	4.38e-05	0.000231	CbGpPWpGaD
Propantheline—CHRM3—Metabolism—CAV1—breast cancer	4.37e-05	0.000231	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—H2AFX—breast cancer	4.37e-05	0.000231	CbGpPWpGaD
Propantheline—CHRM3—GPCR downstream signaling—IL2—breast cancer	4.37e-05	0.00023	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—NRG1—breast cancer	4.36e-05	0.00023	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—E2F1—breast cancer	4.35e-05	0.00023	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—E2F1—breast cancer	4.34e-05	0.000229	CbGpPWpGaD
Propantheline—CHRM1—Signaling by GPCR—PIK3CB—breast cancer	4.33e-05	0.000229	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—H2AFX—breast cancer	4.33e-05	0.000228	CbGpPWpGaD
Propantheline—CHRM2—GPCR downstream signaling—IL2—breast cancer	4.33e-05	0.000228	CbGpPWpGaD
Propantheline—CHRM3—Signaling by GPCR—PIK3CB—breast cancer	4.32e-05	0.000228	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—E2F1—breast cancer	4.3e-05	0.000227	CbGpPWpGaD
Propantheline—CHRM2—Signaling by GPCR—PIK3CB—breast cancer	4.28e-05	0.000226	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—SPP1—breast cancer	4.18e-05	0.000221	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—SPP1—breast cancer	4.17e-05	0.00022	CbGpPWpGaD
Propantheline—CHRM1—Signaling by GPCR—CXCL8—breast cancer	4.16e-05	0.00022	CbGpPWpGaD
Propantheline—CHRM3—Signaling by GPCR—CXCL8—breast cancer	4.15e-05	0.000219	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—ERBB3—breast cancer	4.14e-05	0.000218	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—FGFR2—breast cancer	4.13e-05	0.000218	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—SPP1—breast cancer	4.13e-05	0.000218	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—ERBB3—breast cancer	4.12e-05	0.000218	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—FGFR2—breast cancer	4.12e-05	0.000217	CbGpPWpGaD
Propantheline—CHRM2—Signaling by GPCR—CXCL8—breast cancer	4.11e-05	0.000217	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—ERBB3—breast cancer	4.08e-05	0.000215	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—FGFR2—breast cancer	4.08e-05	0.000215	CbGpPWpGaD
Propantheline—CHRM3—Metabolism—PIK3CG—breast cancer	3.98e-05	0.00021	CbGpPWpGaD
Propantheline—CHRM1—Signaling by GPCR—IL2—breast cancer	3.98e-05	0.00021	CbGpPWpGaD
Propantheline—CHRM3—Signaling by GPCR—IL2—breast cancer	3.97e-05	0.000209	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—TERT—breast cancer	3.97e-05	0.000209	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—TERT—breast cancer	3.95e-05	0.000208	CbGpPWpGaD
Propantheline—CHRM2—Signaling by GPCR—IL2—breast cancer	3.93e-05	0.000207	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—TERT—breast cancer	3.91e-05	0.000206	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—FGFR1—breast cancer	3.85e-05	0.000203	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—FGFR1—breast cancer	3.84e-05	0.000202	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—FGFR1—breast cancer	3.8e-05	0.0002	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—HIF1A—breast cancer	3.79e-05	0.0002	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—HIF1A—breast cancer	3.78e-05	0.000199	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—HIF1A—breast cancer	3.74e-05	0.000197	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—LEP—breast cancer	3.7e-05	0.000195	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—LEP—breast cancer	3.69e-05	0.000195	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—CAV1—breast cancer	3.67e-05	0.000193	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—CAV1—breast cancer	3.66e-05	0.000193	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—LEP—breast cancer	3.65e-05	0.000193	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—KDR—breast cancer	3.63e-05	0.000191	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—CAV1—breast cancer	3.62e-05	0.000191	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—KDR—breast cancer	3.62e-05	0.000191	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—KDR—breast cancer	3.58e-05	0.000189	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—ESR1—breast cancer	3.53e-05	0.000186	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—ESR1—breast cancer	3.52e-05	0.000186	CbGpPWpGaD
Propantheline—CHRM3—Metabolism—PIK3CD—breast cancer	3.5e-05	0.000185	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—FN1—breast cancer	3.49e-05	0.000184	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—ESR1—breast cancer	3.49e-05	0.000184	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—FN1—breast cancer	3.48e-05	0.000184	CbGpPWpGaD
Propantheline—CHRM3—Metabolism—ALB—breast cancer	3.46e-05	0.000182	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—NFKBIA—breast cancer	3.45e-05	0.000182	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—FN1—breast cancer	3.45e-05	0.000182	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—NFKBIA—breast cancer	3.44e-05	0.000181	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—NOTCH1—breast cancer	3.42e-05	0.00018	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—NOTCH1—breast cancer	3.41e-05	0.00018	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—NFKBIA—breast cancer	3.41e-05	0.00018	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—NOTCH1—breast cancer	3.37e-05	0.000178	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—APC—breast cancer	3.34e-05	0.000176	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—KIT—breast cancer	3.34e-05	0.000176	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—PIK3CG—breast cancer	3.34e-05	0.000176	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—KIT—breast cancer	3.33e-05	0.000176	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—APC—breast cancer	3.33e-05	0.000176	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—PIK3CG—breast cancer	3.33e-05	0.000176	CbGpPWpGaD
Propantheline—CHRM3—Metabolism—NOS3—breast cancer	3.31e-05	0.000174	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—EGF—breast cancer	3.3e-05	0.000174	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—KIT—breast cancer	3.3e-05	0.000174	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—APC—breast cancer	3.3e-05	0.000174	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—PIK3CG—breast cancer	3.3e-05	0.000174	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—EGF—breast cancer	3.29e-05	0.000174	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—EGF—breast cancer	3.26e-05	0.000172	CbGpPWpGaD
Propantheline—CHRM1—Signaling by GPCR—MAPK3—breast cancer	3.2e-05	0.000169	CbGpPWpGaD
Propantheline—CHRM3—Signaling by GPCR—MAPK3—breast cancer	3.19e-05	0.000168	CbGpPWpGaD
Propantheline—CHRM2—Signaling by GPCR—MAPK3—breast cancer	3.16e-05	0.000167	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—BRAF—breast cancer	3.14e-05	0.000166	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—BRAF—breast cancer	3.13e-05	0.000165	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—BRAF—breast cancer	3.1e-05	0.000163	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—IGF1—breast cancer	3.06e-05	0.000161	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—AKT2—breast cancer	3.06e-05	0.000161	CbGpPWpGaD
Propantheline—CHRM3—Metabolism—PIK3CB—breast cancer	3.05e-05	0.000161	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—IGF1—breast cancer	3.05e-05	0.000161	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—AKT2—breast cancer	3.05e-05	0.000161	CbGpPWpGaD
Propantheline—CHRM1—Signaling by GPCR—EGFR—breast cancer	3.04e-05	0.000161	CbGpPWpGaD
Propantheline—CHRM3—Signaling by GPCR—EGFR—breast cancer	3.03e-05	0.00016	CbGpPWpGaD
Propantheline—CHRM3—Metabolism—PTGS2—breast cancer	3.02e-05	0.000159	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—IGF1—breast cancer	3.02e-05	0.000159	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—AKT2—breast cancer	3.02e-05	0.000159	CbGpPWpGaD
Propantheline—CHRM2—Signaling by GPCR—EGFR—breast cancer	3e-05	0.000158	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—PIK3CD—breast cancer	2.94e-05	0.000155	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—PIK3CD—breast cancer	2.93e-05	0.000154	CbGpPWpGaD
Propantheline—CHRM1—GPCR downstream signaling—PIK3CA—breast cancer	2.91e-05	0.000153	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—SERPINE1—breast cancer	2.91e-05	0.000153	CbGpPWpGaD
Propantheline—CHRM3—GPCR downstream signaling—PIK3CA—breast cancer	2.9e-05	0.000153	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—PIK3CD—breast cancer	2.9e-05	0.000153	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—SERPINE1—breast cancer	2.9e-05	0.000153	CbGpPWpGaD
Propantheline—CHRM1—Signaling by GPCR—KRAS—breast cancer	2.88e-05	0.000152	CbGpPWpGaD
Propantheline—CHRM2—GPCR downstream signaling—PIK3CA—breast cancer	2.87e-05	0.000151	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—SERPINE1—breast cancer	2.87e-05	0.000151	CbGpPWpGaD
Propantheline—CHRM3—Signaling by GPCR—KRAS—breast cancer	2.87e-05	0.000151	CbGpPWpGaD
Propantheline—CHRM2—Signaling by GPCR—KRAS—breast cancer	2.84e-05	0.00015	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—NOS3—breast cancer	2.77e-05	0.000146	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—NOS3—breast cancer	2.76e-05	0.000146	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—NOS3—breast cancer	2.74e-05	0.000144	CbGpPWpGaD
Propantheline—CHRM1—Signaling by GPCR—PIK3CA—breast cancer	2.64e-05	0.000139	CbGpPWpGaD
Propantheline—CHRM3—Metabolism—PTEN—breast cancer	2.64e-05	0.000139	CbGpPWpGaD
Propantheline—CHRM3—Signaling by GPCR—PIK3CA—breast cancer	2.63e-05	0.000139	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—MDM2—breast cancer	2.63e-05	0.000139	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—MDM2—breast cancer	2.62e-05	0.000138	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—RAF1—breast cancer	2.62e-05	0.000138	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—RAF1—breast cancer	2.61e-05	0.000138	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—RELA—breast cancer	2.61e-05	0.000138	CbGpPWpGaD
Propantheline—CHRM2—Signaling by GPCR—PIK3CA—breast cancer	2.61e-05	0.000138	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—RELA—breast cancer	2.6e-05	0.000137	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—MDM2—breast cancer	2.6e-05	0.000137	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—ERBB2—breast cancer	2.59e-05	0.000137	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—RAF1—breast cancer	2.59e-05	0.000137	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—ERBB2—breast cancer	2.59e-05	0.000136	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—RELA—breast cancer	2.58e-05	0.000136	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—ERBB2—breast cancer	2.56e-05	0.000135	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—PIK3CB—breast cancer	2.56e-05	0.000135	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—MTOR—breast cancer	2.56e-05	0.000135	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—PIK3CB—breast cancer	2.55e-05	0.000135	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—MTOR—breast cancer	2.55e-05	0.000135	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—PIK3CB—breast cancer	2.53e-05	0.000133	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—MTOR—breast cancer	2.53e-05	0.000133	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—CXCL8—breast cancer	2.46e-05	0.00013	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—CXCL8—breast cancer	2.45e-05	0.000129	CbGpPWpGaD
Propantheline—CHRM1—Signaling by GPCR—HRAS—breast cancer	2.44e-05	0.000129	CbGpPWpGaD
Propantheline—CHRM3—Signaling by GPCR—HRAS—breast cancer	2.44e-05	0.000128	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—CXCL8—breast cancer	2.43e-05	0.000128	CbGpPWpGaD
Propantheline—CHRM2—Signaling by GPCR—HRAS—breast cancer	2.41e-05	0.000127	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—CDKN1B—breast cancer	2.4e-05	0.000127	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—CDKN1B—breast cancer	2.4e-05	0.000126	CbGpPWpGaD
Propantheline—CHRM1—GPCR downstream signaling—AKT1—breast cancer	2.38e-05	0.000125	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—CDKN1B—breast cancer	2.37e-05	0.000125	CbGpPWpGaD
Propantheline—CHRM3—GPCR downstream signaling—AKT1—breast cancer	2.37e-05	0.000125	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—CASP3—breast cancer	2.35e-05	0.000124	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—IL2—breast cancer	2.35e-05	0.000124	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—CASP3—breast cancer	2.35e-05	0.000124	CbGpPWpGaD
Propantheline—CHRM2—GPCR downstream signaling—AKT1—breast cancer	2.35e-05	0.000124	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—IL2—breast cancer	2.34e-05	0.000124	CbGpPWpGaD
Propantheline—CHRM1—Signaling by GPCR—IL6—breast cancer	2.34e-05	0.000123	CbGpPWpGaD
Propantheline—CHRM3—Signaling by GPCR—IL6—breast cancer	2.33e-05	0.000123	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—CASP3—breast cancer	2.32e-05	0.000123	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—IL2—breast cancer	2.32e-05	0.000122	CbGpPWpGaD
Propantheline—CHRM2—Signaling by GPCR—IL6—breast cancer	2.31e-05	0.000122	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—CCND1—breast cancer	2.29e-05	0.000121	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—JUN—breast cancer	2.29e-05	0.000121	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—CCND1—breast cancer	2.28e-05	0.00012	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—JUN—breast cancer	2.28e-05	0.00012	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—CTNNB1—breast cancer	2.27e-05	0.00012	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—CTNNB1—breast cancer	2.26e-05	0.000119	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—CCND1—breast cancer	2.26e-05	0.000119	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—JUN—breast cancer	2.26e-05	0.000119	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—CTNNB1—breast cancer	2.24e-05	0.000118	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—MMP9—breast cancer	2.23e-05	0.000117	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—MMP9—breast cancer	2.22e-05	0.000117	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—CDKN1A—breast cancer	2.22e-05	0.000117	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—PTEN—breast cancer	2.21e-05	0.000117	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—CDKN1A—breast cancer	2.21e-05	0.000117	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—PTEN—breast cancer	2.21e-05	0.000116	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—MMP9—breast cancer	2.2e-05	0.000116	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—CDKN1A—breast cancer	2.19e-05	0.000115	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—PTEN—breast cancer	2.18e-05	0.000115	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—MAPK8—breast cancer	2.16e-05	0.000114	CbGpPWpGaD
Propantheline—CHRM1—Signaling by GPCR—AKT1—breast cancer	2.16e-05	0.000114	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—MAPK8—breast cancer	2.16e-05	0.000114	CbGpPWpGaD
Propantheline—CHRM3—Signaling by GPCR—AKT1—breast cancer	2.15e-05	0.000113	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—MAPK8—breast cancer	2.14e-05	0.000113	CbGpPWpGaD
Propantheline—CHRM2—Signaling by GPCR—AKT1—breast cancer	2.13e-05	0.000112	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—SRC—breast cancer	2.05e-05	0.000108	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—SRC—breast cancer	2.05e-05	0.000108	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—SRC—breast cancer	2.03e-05	0.000107	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—VEGFA—breast cancer	2e-05	0.000105	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—VEGFA—breast cancer	1.99e-05	0.000105	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—STAT3—breast cancer	1.98e-05	0.000104	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—VEGFA—breast cancer	1.97e-05	0.000104	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—STAT3—breast cancer	1.97e-05	0.000104	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—STAT3—breast cancer	1.95e-05	0.000103	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—MAPK3—breast cancer	1.89e-05	9.97e-05	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—MAPK3—breast cancer	1.88e-05	9.94e-05	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—MAPK3—breast cancer	1.87e-05	9.84e-05	CbGpPWpGaD
Propantheline—CHRM3—Metabolism—PIK3CA—breast cancer	1.86e-05	9.81e-05	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—MYC—breast cancer	1.84e-05	9.7e-05	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—TGFB1—breast cancer	1.83e-05	9.67e-05	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—MYC—breast cancer	1.83e-05	9.66e-05	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—TGFB1—breast cancer	1.83e-05	9.64e-05	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—MYC—breast cancer	1.81e-05	9.57e-05	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—TGFB1—breast cancer	1.81e-05	9.55e-05	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—EGFR—breast cancer	1.8e-05	9.48e-05	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—EGFR—breast cancer	1.79e-05	9.45e-05	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—EGFR—breast cancer	1.78e-05	9.36e-05	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—KRAS—breast cancer	1.7e-05	8.96e-05	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—KRAS—breast cancer	1.69e-05	8.93e-05	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—KRAS—breast cancer	1.68e-05	8.84e-05	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—PIK3CA—breast cancer	1.56e-05	8.23e-05	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—PIK3CA—breast cancer	1.56e-05	8.2e-05	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—PIK3CA—breast cancer	1.54e-05	8.12e-05	CbGpPWpGaD
Propantheline—CHRM3—Metabolism—AKT1—breast cancer	1.52e-05	8.02e-05	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—TP53—breast cancer	1.51e-05	7.96e-05	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—TP53—breast cancer	1.51e-05	7.94e-05	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—TP53—breast cancer	1.49e-05	7.86e-05	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—HRAS—breast cancer	1.44e-05	7.61e-05	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—HRAS—breast cancer	1.44e-05	7.59e-05	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—HRAS—breast cancer	1.43e-05	7.52e-05	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—IL6—breast cancer	1.38e-05	7.29e-05	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—IL6—breast cancer	1.38e-05	7.26e-05	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—IL6—breast cancer	1.36e-05	7.19e-05	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—AKT1—breast cancer	1.27e-05	6.72e-05	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—AKT1—breast cancer	1.27e-05	6.7e-05	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—AKT1—breast cancer	1.26e-05	6.64e-05	CbGpPWpGaD
